Evidence map›Paper›PMID 41496755›Full record

ArticleStructural heart : the journal of the Heart Team2025

Impact of Prior Q-Wave Myocardial Infarction in Transcatheter Aortic Valve Replacement Patients With Reduced Ejection Fraction.

Siddhartha Mengi, Marina Urena, Gabriela Veiga-Fernandez, Alberto Alperi, Luis Nombela-Franco, Victoria Vilalta, Ander Regueiro, Jules Mesnier, Victor Fradejas-Sastre, Pablo Avanzas and 6 more

Abstract read
In one paragraph

Article in Structural heart : the journal of the Heart Team, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Siddhartha MengiQuebec Heart & Lung Institute, Laval University, Quebec City, Quebec, Canada.
Marina UrenaDepartment of Cardiology, Hospital Bichat Claude-Bernard, Paris, France.
Gabriela Veiga-FernandezCardiology Department, Hospital Universitario Marqués de Valdecilla, Instituto de Investigación Valdecilla (IDIVAL), Santander, Spain.
Alberto AlperiDepartment of Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain.
Luis Nombela-FrancoCardiovascular Institute, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
Victoria VilaltaDepartment of Cardiology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Ander RegueiroDepartment of Cardiology, Instituto Clínic Cardiovascular, Hospital Clínic, and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Jules MesnierDepartment of Cardiology, Hospital Bichat Claude-Bernard, Paris, France.
Victor Fradejas-SastreCardiology Department, Hospital Universitario Marqués de Valdecilla, Instituto de Investigación Valdecilla (IDIVAL), Santander, Spain.
Pablo AvanzasDepartment of Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain.
Ricardo Ortiz LozadaCardiovascular Institute, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
Elena de Oliveira-CañedoDepartment of Cardiology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Giovanni OcchipintiDepartment of Cardiology, Instituto Clínic Cardiovascular, Hospital Clínic, and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Pedro Cepas-GuillénQuebec Heart & Lung Institute, Laval University, Quebec City, Quebec, Canada.
Marisa AvvedimentoQuebec Heart & Lung Institute, Laval University, Quebec City, Quebec, Canada.
Josep Rodés-CabauQuebec Heart & Lung Institute, Laval University, Quebec City, Quebec, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Coronary artery disease is prevalent in transcatheter aortic valve replacement (TAVR) patients, but the specific impact of prior Q-wave myocardial infarction (QWMI), a marker of transmural infarction, remains underexplored. This study evaluated the clinical impact of QWMI in TAVR patients with left ventricular ejection fraction (LVEF) ​< ​50%. Methods: Multicenter study including 1172 consecutive patients undergoing TAVR with contemporary devices, stratified according to prior QWMI. The primary outcome was all-cause mortality or heart failure hospitalization (HFH) over a median follow-up of 3 (1-4) years. Secondary endpoints included changes in LVEF and independent predictors of adverse outcomes. Results: Prior QWMI was present in 106 (9.0%) patients. Those with QWMI were younger (77.3 vs 80.6 years; Conclusions: Up to 1 out of 10 TAVR patients with reduced LVEF had prior QWMI, which was associated with impaired LVEF recovery, especially in those with anterior QWMI, and worse clinical outcomes at 3-year follow-up, largely driven by comorbidities. These findings underscore the importance of advanced preprocedural imaging, tailored therapeutic strategies, and integrated multidisciplinary care to enhance outcomes in this high-risk TAVR population.

Indexed as

CADLVEFQ-wave MITAVR

Identifiers

PMID41496755
PMCPMC12766498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.